4.7 Article

Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA)

Journal

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 30, Issue 1, Pages 72-77

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijantimicag.2007.02.007

Keywords

CA-MRSA; endocarditis; USA300; vancomycin

Funding

  1. PHS HHS [R01/CCR5234523452] Funding Source: Medline

Ask authors/readers for more resources

We report seven cases of infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA) at an urban, tertiary care, academic institution. Five strains were community associated and two were healthcare associated. All patients were injection drug users. Staphylococcus aureus isolates were characterised as USA300-type MRSA using pulsed-field gel electrophoresis. Five cases were right-sided endocarditis and two cases were left-sided. The mean length of in-hospital antimicrobial therapy was 23 days and the mean length of total antibiotic therapy was 55 days. Complications included heart failure resulting in valve replacement in one patient as well as death in that patient. As USA300 strains of MRSA continue to increase in prevalence, clinicians must be aware of the increasing spectrum of illness in considering management and prevention strategies. (c) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available